...
首页> 外文期刊>Nanotechnology >Control generating of bacterial magnetic nanoparticle-doxorubicin conjugates by poly-L-glutamic acid surface modification
【24h】

Control generating of bacterial magnetic nanoparticle-doxorubicin conjugates by poly-L-glutamic acid surface modification

机译:通过聚-L-谷氨酸表面改性来控制细菌磁性纳米颗粒-阿霉素结合物的产生

获取原文
获取原文并翻译 | 示例
           

摘要

By using poly-L-glutamic acid (PLGA) to modify the membrane surface of bacterial magnetic nanoparticles (BMPs), (BMP)-doxorubicin conjugates (DBMP-P) could be control generated. The doxorubicin loading ratio could be raised up to 81.7% (w/w) in comparison with that of dual functional linkers. DBMP-P was characterized by transmission electron micrographs, attenuated total reflection infrared spectroscopy, magnetic properties, and dynamic light scattering. It is found that increase of the doxorubicin/PLGA modified BMP (PBMP) ratio leads to an increase of the drug loading ratio and a decrease of saturation magnetization. Besides, DBMP-P is sensitive to pH to facilitate drug release, shows enhancement of uptake by cancer cells, and is strongly cytotoxic to HePG2 and MCF-7 cells.
机译:通过使用聚-L-谷氨酸(PLGA)修饰细菌磁性纳米颗粒(BMP)的膜表面,可以控制(BMP)-阿霉素结合物(DBMP-P)的生成。与双功能接头相比,阿霉素的负载率可提高至81.7%(w / w)。 DBMP-P的特征在于透射电子显微镜,衰减全反射红外光谱,磁性能和动态光散射。已经发现,阿霉素/ PLGA修饰的BMP(PBMP)比的增加导致药物载量比的增加和饱和磁化强度的降低。此外,DBMP-P对pH敏感,有利于药物释放,显示出癌细胞摄取的增强,并且对HePG2和MCF-7细胞具有强烈的细胞毒性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号